Form 4: Elanco Animal Health Executive Rajeev A. Modi Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units representing the right to receive common stock or cash equivalent.

Summary

  • Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc., filed a Form 4 on September 10, 2024, reporting a transaction.
  • The transaction involved the acquisition of deferred stock units on September 6, 2024.
  • Modi acquired 91.7575 deferred stock units at a price of $15.09 each, resulting in a total of 1,652.2587 deferred stock units owned directly.
  • Each deferred stock unit represents the right to receive one share of Elanco Animal Health common stock or the cash equivalent upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard executive compensation practice, indicating confidence in the company's future.

Positives

  • The acquisition of deferred stock units indicates a continued investment and alignment of interests between the executive and the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation through deferred stock units is a common practice in publicly traded companies to incentivize long-term performance and align executive interests with shareholder value.

Comparison to Industry Standards

  • Deferred stock units are a typical component of executive compensation packages in the animal health and pharmaceutical industries.
  • Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans to attract and retain top talent.
  • The vesting and settlement terms of these units often vary based on company performance and executive tenure, aligning with industry best practices.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns executive interests with the company's long-term performance.

Key Dates

DateDescription
09/06/2024Date of transaction: Acquisition of deferred stock units.
09/10/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.